文献速递甲状腺疾病

自身免疫性甲状腺疾病中的DNA甲基化

DNA Methylation in Autoimmune Thyroid Disease.
PubMed 文献 · J Clin Endocrinol Metab · 2023-01-01

本文综述了DNA甲基化在自身免疫性甲状腺疾病(AITD)中的研究进展,包括候选基因研究和全表观基因组研究的结果。多种基因启动子区DNA甲基化差异已被报道,但许多发现尚待重复且缺乏功能研究支持因果作用。甲状腺激素影响DNA甲基化,反向因果混杂在多研究中未被考虑。碘状态不同地区患者间候选基因甲基化模式存在差异,为碘与AITD关联提供潜在机制。领域正从候选基因研究转向全表观基因组方法,需大规模研究阐明DNA甲基化在AITD中的病理生理作用。

要点

  • AITD患者血液样本中TNF、IFNG、IL2RA、IL6、ICAM1、PTPN22等基因启动子区DNA甲基化存在差异。
  • 许多DNA甲基化发现尚待重复,且缺乏功能研究支持其在AITD发病中的因果作用。
  • 甲状腺激素影响DNA甲基化,反向因果混杂在多研究中未被考虑。

核心结论

  • DNA甲基化提供了环境因素、基因表达与甲状腺自身免疫之间的潜在联系。
  • 许多候选基因DNA甲基化发现尚待重复,且缺乏功能研究支持因果作用。
  • 甲状腺激素影响DNA甲基化,反向因果混杂在多研究中未被考虑。
  • 需大规模全表观基因组研究阐明DNA甲基化在AITD中的病理生理作用,以提供诊断、预后生物标志物和治疗靶点。

研究设计与样本

  • 本文为综述,总结DNA甲基化在AITD中的当前认识。
  • 涵盖靶向DNA甲基化研究和全基因组甲基化研究。

主要发现

  • AITD患者血液样本靶向DNA甲基化研究报告TNF、IFNG、IL2RA、IL6、ICAM1、PTPN22等基因启动子区DNA甲基化差异。
  • 许多发现尚待重复,且缺乏功能研究支持因果作用。
  • 甲状腺激素影响DNA甲基化,反向因果混杂在多研究中未被考虑。
  • 碘状态不同地区AITD患者ITGA6、PRKAA2、DAPK1等候选基因DNA甲基化模式不同。
  • 全基因组甲基化研究显示AITD患者存在多个差异甲基化位点,包括NOTCH1、HLA-DRB1、TNF、ICAM1等免疫调节基因。

局限性

  • 许多DNA甲基化发现尚待重复,且缺乏功能研究支持因果作用。
  • 甲状腺激素影响DNA甲基化,反向因果混杂在多研究中未被考虑。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Graves disease and Hashimoto disease form part of the spectrum of autoimmune thyroid disease (AITD), to which genetic and environmental factors are recognized contributors. Epigenetics provides a potential link between environmental influences, gene expression, and thyroid autoimmunity. DNA methylation (DNAm) is the best studied epigenetic process, and global hypomethylation of leukocyte DNA is reported in several autoimmune disorders. This review summarizes the current understanding of DNAm in AITD. Targeted DNAm studies of blood samples from AITD patients have reported differential DNAm in the promoter regions of several genes implicated in AITD, including TNF, IFNG, IL2RA, IL6, ICAM1, and PTPN22. In many cases, however, the findings await replication and are unsupported by functional studies to support causal roles in AITD pathogenesis. Furthermore, thyroid hormones affect DNAm, and in many studies confounding by reverse causation has not been considered. Recent studies have shown that DNAm patterns in candidate genes including ITGA6, PRKAA2, and DAPK1 differ between AITD patients from regions with different iodine status, providing a potential mechanism for associations between iodine and AITD. Research focus in the field is moving from candidate gene studies to an epigenome-wide approach. Genome-wide methylation studies of AITD patients have demonstrated multiple differentially methylated positions, including some in immunoregulatory genes such as NOTCH1, HLA-DRB1, TNF, and ICAM1. Large, epigenome-wide studies are required to elucidate the pathophysiological role of DNAm in AITD, with the potential to provide novel diagnostic and prognostic biomarkers as well as therapeutic targets.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Lafontaine N, Wilson SG, Walsh JP, et al. DNA Methylation in Autoimmune Thyroid Disease. J Clin Endocrinol Metab. 2023. PMID: 36420742. doi:10.1210/clinem/dgac664

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。